{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:02:13Z","timestamp":1791414133382,"version":"4.3.3"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"suppl_7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,6,1]]},"DOI":"10.1093\/cid\/cir167","type":"journal-article","created":{"date-parts":[[2011,5,5]],"date-time":"2011-05-05T16:53:14Z","timestamp":1304614394000},"page":"S520-S526","source":"Crossref","is-referenced-by-count":44,"title":["A Randomized, Double-Blind Phase 2 Study Comparing the Efficacy and Safety of an Oral Fusidic Acid Loading-Dose Regimen to Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections"],"prefix":"10.1093","volume":"52","author":[{"given":"J. Carl","family":"Craft","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan R.","family":"Moriarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drusilla","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten P.","family":"Degenhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Gordon","family":"Still","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Ralph","family":"Corey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhavathi","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,6,1]]},"reference":[{"key":"key\n\t\t\t\t20171013234110_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-443-06839-3.00090-4","article-title":"Cellulitis, necrotizing fasciitis and subcutaneous tissue infections","volume-title":"Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases","author":"Pasternack","year":"2010","edition":"7th ed."},{"key":"key\n\t\t\t\t20171013234110_bib2","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3181\/00379727-51-13986","article-title":"Resistance of Staphylococcus aureus to the action of penicillin","volume":"51","author":"Rammelkamp","year":"1942","journal-title":"Proc Soc Exp Biol Med"},{"key":"key\n\t\t\t\t20171013234110_bib3","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/bmj.1.5219.124-a","article-title":"\"Celbenin\"-resistant staphylococci","volume":"1","author":"Jevons","year":"1961","journal-title":"Br Med J"},{"key":"key\n\t\t\t\t20171013234110_bib4","doi-asserted-by":"crossref","first-page":"582","DOI":"10.2307\/30148460","article-title":"Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975\u20131991","volume":"13","author":"Panlilio","year":"1992","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key\n\t\t\t\t20171013234110_bib5","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1016\/S0002-9343(98)00349-0","article-title":"Methicillin-resistant Staphylococcus aureus: long-term care concerns","volume":"106","author":"Bradley","year":"1999","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t20171013234110_bib6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.7326\/0003-4819-144-5-200603070-00005","article-title":"Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA clone 300 as the predominant cause of skin and soft-tissue infections","volume":"144","author":"King","year":"2006","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20171013234110_bib7","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1056\/NEJMoa055356","article-title":"Methicillin-resistant S. aureus infections among patients in the emergency department","volume":"355","author":"Moran","year":"2006","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171013234110_bib8","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1086\/427701","article-title":"Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic and therapeutic odyssey","volume":"40","author":"Deresinski","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171013234110_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-443-06839-3.00025-4","article-title":"Fusidic acid","volume-title":"Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases","author":"Mandell","year":"2010","edition":"7th ed."},{"issue":"Suppl 7","key":"key\n\t\t\t\t20171013234110_bib10","doi-asserted-by":"crossref","first-page":"S477","DOI":"10.1093\/cid\/cir163","article-title":"In vitro antimicrobial findings for fusidic acid tested against contemporary (2008\u20132009) gram-positive organisms collected in the United States","volume":"52","author":"Jones","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"Suppl 7","key":"key\n\t\t\t\t20171013234110_bib11","doi-asserted-by":"crossref","first-page":"S513","DOI":"10.1093\/cid\/cir166","article-title":"Application of pharmacokinetic-pharmacodynamic modeling and the justification of a novel fusidic acid dose regimen: raising lazarus from the dead","volume":"52","author":"Tsuji","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171013234110_bib12","volume-title":"Guidance for Industry. Acute bacterial skin and skin structure infections drugs for treatment. Rockville, MD: US Food and Drug Administration","year":"2010"},{"key":"key\n\t\t\t\t20171013234110_bib13","doi-asserted-by":"crossref","first-page":"S368","DOI":"10.1086\/533593","article-title":"Skin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus","volume":"46","author":"Stryjewski","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171013234110_bib14","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1086\/529445","article-title":"Current treatment options for community-acquired methicillin-resistant Staphylococcus aureus infection","volume":"46","author":"Moellering","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171013234110_bib15","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1086\/499367","article-title":"Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992\u20132003","volume":"42","author":"Klevins","year":"2006","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171013234110_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-4632.2007.03215.x","article-title":"Community-acquired methicillin-resistant Staphylococcus aureus skin infections: a review of epidemiology, clinical features, management, and prevention","volume":"46","author":"Cohen","year":"2007","journal-title":"Int J Dermatol"},{"key":"key\n\t\t\t\t20171013234110_bib17","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.3201\/eid1211.060190","article-title":"Staphylococcus aureus-associated skin and soft tissue infections in ambulatory care","volume":"12","author":"McCraig","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20171013234110_bib18","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1086\/511033","article-title":"Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin-susceptible S. aureus infection: a prospective investigation","volume":"44","author":"Miller","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171013234110_bib19","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1086\/377501","article-title":"Failure of clindamycin treatment of methicillin-resistant Staphyolococcus aureus expressing inducible clindamycin resistance in vitro","volume":"37","author":"Siberry","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171013234110_bib20","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1086\/525536","article-title":"Role of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infection","volume":"46","author":"Proctor","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171013234110_bib21","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/S0924-8579(98)00073-9","article-title":"Fusidic acid in vitro activity","volume":"12(Suppl 2)","author":"Collignon","year":"1999","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20171013234110_bib22","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/S0924-8579(98)00071-5","article-title":"Fusidic acid pharmacology, pharmacokinetics and pharmacodynamics","volume":"12(Suppl 2)","author":"Turnidge","year":"1999","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20171013234110_bib23","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1302\/0301-620X.52B2.302","article-title":"Further experience in the management of chronic osteomyelitis","volume":"52","author":"Rowling","year":"1970","journal-title":"J Bone Joint Surg Br"},{"issue":"Suppl. B","key":"key\n\t\t\t\t20171013234110_bib24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/jac\/25.suppl_B.53","article-title":"Fusidic acid in staphylococcal bone and joint infection","volume":"25","author":"Coombs","year":"1990","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 7","key":"key\n\t\t\t\t20171013234110_bib25","doi-asserted-by":"crossref","first-page":"S487","DOI":"10.1093\/cid\/cir164","article-title":"Characterization of global patterns and the genetics of fusidic acid resistance","volume":"52","author":"Farrell","year":"2011","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/52\/suppl_7\/S520\/20910438\/cir167.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T11:25:59Z","timestamp":1560165959000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/cid\/article\/52\/suppl_7\/S520\/269776\/A-Randomized-DoubleBlind-Phase-2-Study-Comparing"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,1]]},"references-count":25,"journal-issue":{"issue":"suppl_7","published-online":{"date-parts":[[2011,6,1]]},"published-print":{"date-parts":[[2011,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/cir167","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published-other":{"date-parts":[[2011,6,1]]},"published":{"date-parts":[[2011,6,1]]}}}